BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16434591)

  • 1. p53 Mutation analysis in breast tumors by a DNA microarray method.
    Tennis M; Krishnan S; Bonner M; Ambrosone CB; Vena JE; Moysich K; Swede H; McCann S; Hall P; Shields PG; Freudenheim JL
    Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):80-5. PubMed ID: 16434591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oligonucleotide probe array for p53 gene alteration analysis in DNA from formalin-fixed paraffin-embedded breast cancer tissues.
    Lumachi F; Marino F; Varotto S; Basso U
    Ann N Y Acad Sci; 2009 Sep; 1175():89-92. PubMed ID: 19796081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of oligonucleotide arrays for sequencing of the p53 gene in DNA from formalin-fixed, paraffin-embedded breast cancer specimens.
    Cooper M; Li SQ; Bhardwaj T; Rohan T; Kandel RA
    Clin Chem; 2004 Mar; 50(3):500-8. PubMed ID: 14726466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular mechanisms of lung cancer development at its different stages in nuclear industry workers].
    Rusinova GG; Vyazovskaya NS; Azizova TV; Revina VS; Glazkova IV; Generozov EV; Zakharzhevskaya NB; Guryanov MY; Belosokhov MV; Osovets SV
    Arkh Patol; 2015; 77(2):10-15. PubMed ID: 26027393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid sequencing of the p53 gene with a new automated DNA sequencer.
    Bharaj BS; Angelopoulou K; Diamandis EP
    Clin Chem; 1998 Jul; 44(7):1397-403. PubMed ID: 9665415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection of point mutation of p53 gene by non-isotopic PCR-SSCP in paraffin-embedded breast cancer tissue].
    Chen YH; Dong JP; Zhang SJ
    Zhonghua Bing Li Xue Za Zhi; 1994 Dec; 23(6):327-9. PubMed ID: 7720108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple mutations of the p53 gene in human mammary carcinoma.
    Meng L; Lin L; Zhang H; Nassiri M; Morales AR; Nadji M
    Mutat Res; 1999 Dec; 435(3):263-9. PubMed ID: 10606817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
    Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
    Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving the detection of p53 mutations in breast cancer by use of the FASAY, a functional assay.
    Duddy PM; Hanby AM; Barnes DM; Camplejohn RS
    J Mol Diagn; 2000 Aug; 2(3):139-44. PubMed ID: 11229518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.
    Hedau S; Jain N; Husain SA; Mandal AK; Ray G; Shahid M; Kant R; Gupta V; Shukla NK; Deo SS; Das BC
    Breast Cancer Res Treat; 2004 Nov; 88(2):177-86. PubMed ID: 15564800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency and pattern of p53 gene mutation in a cohort of Spanish women with node-negative breast cancer.
    Meng L; Lin L; Fresno M; Morales AR; Nadji M
    Int J Oncol; 1999 Sep; 15(3):555-8. PubMed ID: 10427139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is it possible to diagnose malignancy from fluid in cystic ovarian tumors?
    Yamada R; Maeda N; Oguri H; Adachi Y; Takeuchi T; Furihata M; Fukaya T
    Eur J Obstet Gynecol Reprod Biol; 2013 Nov; 171(1):96-100. PubMed ID: 24017961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thirteen new p53 gene mutants identified among 41 human breast cancer cell lines.
    Wasielewski M; Elstrodt F; Klijn JG; Berns EM; Schutte M
    Breast Cancer Res Treat; 2006 Sep; 99(1):97-101. PubMed ID: 16541312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel method for PIK3CA mutation analysis: locked nucleic acid--PCR sequencing.
    Ang D; O'Gara R; Schilling A; Beadling C; Warrick A; Troxell ML; Corless CL
    J Mol Diagn; 2013 May; 15(3):312-8. PubMed ID: 23541593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High frequency and heterogeneous distribution of p53 mutations in aflatoxin B1-induced mouse lung tumors.
    Tam AS; Foley JF; Devereux TR; Maronpot RR; Massey TE
    Cancer Res; 1999 Aug; 59(15):3634-40. PubMed ID: 10446974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid and sensitive p53 alteration analysis in biopsies from lung cancer patients using a functional assay and a universal oligonucleotide array: a prospective study.
    Fouquet C; Antoine M; Tisserand P; Favis R; Wislez M; Commo F; Rabbe N; Carette MF; Milleron B; Barany F; Cadranel J; Zalcman G; Soussi T
    Clin Cancer Res; 2004 May; 10(10):3479-89. PubMed ID: 15161705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A distinct mutational spectrum of p53 and K-ras genes in lung cancer of workers with silicosis.
    Liu B; Guan R; Zhou P; Miao Q; Wang H; Fu D; You B
    J Environ Pathol Toxicol Oncol; 2000; 19(1-2):1-7. PubMed ID: 10905501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 mutations in human lung tumors.
    Miller CW; Simon K; Aslo A; Kok K; Yokota J; Buys CH; Terada M; Koeffler HP
    Cancer Res; 1992 Apr; 52(7):1695-8. PubMed ID: 1312896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 mutations and expression in breast carcinoma in situ.
    Lukas J; Niu N; Press MF
    Am J Pathol; 2000 Jan; 156(1):183-91. PubMed ID: 10623666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of p53 mutations in ThinPrep-processed fine needle breast aspirates with surgically resected breast cancers.
    Pollett A; Bedard YC; Li SQ; Rohan T; Kandel R
    Mod Pathol; 2000 Nov; 13(11):1173-9. PubMed ID: 11106073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.